IN2012DN00640A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00640A IN2012DN00640A IN640DEN2012A IN2012DN00640A IN 2012DN00640 A IN2012DN00640 A IN 2012DN00640A IN 640DEN2012 A IN640DEN2012 A IN 640DEN2012A IN 2012DN00640 A IN2012DN00640 A IN 2012DN00640A
- Authority
- IN
- India
- Prior art keywords
- variable domains
- hosts
- ligands
- vectors
- compositions
- Prior art date
Links
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22602809P | 2009-07-16 | 2009-07-16 | |
| US30755410P | 2010-02-24 | 2010-02-24 | |
| PCT/EP2010/060112 WO2011006915A2 (fr) | 2009-07-16 | 2010-07-14 | Domaines variables uniques de liaison anti-albumine sérique améliorés |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00640A true IN2012DN00640A (fr) | 2015-08-21 |
Family
ID=42829253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN640DEN2012 IN2012DN00640A (fr) | 2009-07-16 | 2010-07-14 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8679496B2 (fr) |
| EP (1) | EP2454285A2 (fr) |
| JP (1) | JP2012532620A (fr) |
| KR (1) | KR20120038494A (fr) |
| CN (1) | CN102574914A (fr) |
| AU (1) | AU2010272590B2 (fr) |
| BR (1) | BR112012001681A2 (fr) |
| CA (1) | CA2768462A1 (fr) |
| EA (1) | EA201270174A1 (fr) |
| IL (1) | IL217520A0 (fr) |
| IN (1) | IN2012DN00640A (fr) |
| MX (1) | MX2012000765A (fr) |
| SG (1) | SG177601A1 (fr) |
| WO (1) | WO2011006915A2 (fr) |
| ZA (1) | ZA201200276B (fr) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA022925B1 (ru) * | 2009-02-19 | 2016-03-31 | Глаксо Груп Лимитед | Улучшенные полипептиды, вариабельные домены антител и антагонисты против tnfr1 |
| CA2768462A1 (fr) * | 2009-07-16 | 2011-01-20 | Glaxo Group Ltd. | Domaines variables uniques de liaison anti-albumine serique ameliores |
| JP2013538566A (ja) * | 2010-08-13 | 2013-10-17 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド | 改良された抗血清アルブミン結合変異体 |
| EP2646467A2 (fr) * | 2010-12-01 | 2013-10-09 | Glaxo Group Limited | Domaines variables améliorés à liaison unique d'anti-albumine sérique |
| SI2776466T1 (sl) | 2011-11-11 | 2017-12-29 | Ucb Biopharma Sprl | Protitelesa, ki se vežejo na albumin in njihovi vezavni fragmenti |
| GB201200563D0 (en) * | 2012-01-13 | 2012-02-29 | Imp Innovations Ltd | Binding molecule |
| WO2017041114A2 (fr) * | 2015-09-03 | 2017-03-09 | The Children's Mercy Hospital | Gènes d'anticorps anti-nicotinamide phosphoribosyltransférase et leurs procédés d'utilisation |
| NO2768984T3 (fr) | 2015-11-12 | 2018-06-09 | ||
| PL3374392T3 (pl) * | 2015-11-13 | 2022-03-28 | Ablynx Nv | Ulepszone domeny zmienne immunoglobuliny wiążące albuminę surowicy |
| CA3132021C (fr) | 2015-11-18 | 2024-03-12 | Merck Sharp & Dohme Corp. | Liants de pd1 et/ou lag3 |
| AU2016355569B2 (en) | 2015-11-18 | 2020-01-02 | Merck Sharp & Dohme Llc | CTLA4 binders |
| AU2016355568A1 (en) | 2015-11-18 | 2018-06-21 | Merck Sharp & Dohme Llc | PD1/CTLA4 Binders |
| CA3005488A1 (fr) | 2015-11-18 | 2017-05-26 | Ablynx Nv | Liants d'albumine serique ameliores |
| CN110049997B (zh) * | 2016-12-07 | 2023-09-22 | 埃博灵克斯股份有限公司 | 改进的血清白蛋白结合免疫球蛋白单可变结构域 |
| US11414481B2 (en) * | 2017-01-17 | 2022-08-16 | Ablynx N.V. | Serum albumin binders |
| BR112019014600A2 (pt) * | 2017-01-17 | 2020-02-18 | Ablynx N.V. | Ligantes de albumina sérica melhorados |
| AU2018220516A1 (en) | 2017-02-16 | 2019-09-19 | Sonnet BioTherapeutics, Inc. | Albumin binding domain fusion proteins |
| MA50352A (fr) | 2017-10-10 | 2020-08-19 | Numab Therapeutics AG | Anticorps multispécifiques |
| EP3470426A1 (fr) | 2017-10-10 | 2019-04-17 | Numab Therapeutics AG | Anticorps multi-spécifique |
| CN113508134A (zh) * | 2019-02-22 | 2021-10-15 | 安维达生物科技公司 | 白蛋白结合抗体及其用途 |
| EP3816185A1 (fr) | 2019-11-04 | 2021-05-05 | Numab Therapeutics AG | Anticorps multi-spécifique contra pd-l1 et antigène associé à une tumeur |
| GB201919061D0 (en) | 2019-12-20 | 2020-02-05 | Ucb Biopharma Sprl | Multi-specific antibody |
| WO2021205183A1 (fr) | 2020-04-09 | 2021-10-14 | Autolus Limited | Polypeptide |
| GB202007441D0 (en) | 2020-05-19 | 2020-07-01 | Autolus Ltd | Polypeptide |
| EP3915580A1 (fr) | 2020-05-29 | 2021-12-01 | Numab Therapeutics AG | Anticorps multi-spécifique |
| EP3988568A1 (fr) | 2020-10-21 | 2022-04-27 | Numab Therapeutics AG | Traitement combiné |
| JP2023551981A (ja) | 2020-12-07 | 2023-12-13 | ユーシービー バイオファルマ エスアールエル | 多重特異性抗体及び抗体の組み合わせ |
| AU2022215847A1 (en) | 2021-02-02 | 2023-08-10 | Numab Therapeutics AG | Multispecific antibodies having specificity for ror1 and cd3 |
| EP4183800A1 (fr) | 2021-11-19 | 2023-05-24 | Medizinische Hochschule Hannover | Nouveaux anticorps neutralisants du sars-cov-2 |
| WO2024038095A1 (fr) | 2022-08-16 | 2024-02-22 | Iome Bio | Nouveaux anticorps anti-rgmb |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| AU2002314495A1 (en) * | 2001-06-20 | 2003-01-02 | Prochon Biotech Ltd. | Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| US20100081792A1 (en) * | 2001-06-28 | 2010-04-01 | Smithkline Beecham Corporation | Ligand |
| EP1517921B1 (fr) | 2002-06-28 | 2006-06-07 | Domantis Limited | Ligands a specificite double et avec une demi-vie augmentee |
| US9321832B2 (en) * | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| PT1737962E (pt) | 2004-03-24 | 2010-12-03 | Domantis Ltd | Sequência líder universal gas1 |
| WO2005118642A2 (fr) | 2004-06-01 | 2005-12-15 | Domantis Limited | Compositions de medicaments, fusions et conjugues |
| US7563443B2 (en) * | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
| AU2005311099B2 (en) * | 2004-12-02 | 2012-02-02 | Domantis Limited | Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
| GB0521621D0 (en) * | 2005-10-24 | 2005-11-30 | Domantis Ltd | Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases |
| JP2009519011A (ja) * | 2005-12-01 | 2009-05-14 | ドマンティス リミテッド | インターロイキン１受容体１型に結合する非競合ドメイン抗体フォーマット |
| CN101466734A (zh) * | 2005-12-01 | 2009-06-24 | 杜门蒂斯有限公司 | 与白细胞介素-1受体1型结合的竞争性域抗体形式 |
| EA013878B1 (ru) * | 2005-12-06 | 2010-08-30 | Домантис Лимитед | Лиганды, имеющие специфичность связывания в отношении рецептора эпидермального фактора роста (egfr) и/или сосудистого эндотелиального фактора роста (vegf), и способы их применения |
| EP2441838A3 (fr) | 2006-01-24 | 2013-07-10 | Domantis Limited | Protéines de fusion contenant des jonctions naturelles |
| WO2007085815A2 (fr) * | 2006-01-24 | 2007-08-02 | Domantis Limited | Ligands qui lient il-4 et/ou il-13 |
| CA2688433A1 (fr) | 2007-06-06 | 2008-12-11 | Domantis Limited | Procede de selection de polypeptides resistant aux proteases |
| WO2009149143A1 (fr) * | 2008-06-03 | 2009-12-10 | E. I. Du Pont De Nemours And Company | Adhérence de polyamides à des résines époxy |
| US8906035B2 (en) * | 2008-06-04 | 2014-12-09 | Ethicon Endo-Surgery, Inc. | Endoscopic drop off bag |
| AU2009256169A1 (en) * | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Compositions and methods comprising variant microbial proteases |
| US10198891B2 (en) * | 2008-06-06 | 2019-02-05 | Epona Llc | System and method for regulating fuel transactions |
| CA2768462A1 (fr) * | 2009-07-16 | 2011-01-20 | Glaxo Group Ltd. | Domaines variables uniques de liaison anti-albumine serique ameliores |
-
2010
- 2010-07-14 CA CA2768462A patent/CA2768462A1/fr not_active Abandoned
- 2010-07-14 US US13/384,316 patent/US8679496B2/en not_active Expired - Fee Related
- 2010-07-14 EP EP10734965A patent/EP2454285A2/fr not_active Withdrawn
- 2010-07-14 MX MX2012000765A patent/MX2012000765A/es not_active Application Discontinuation
- 2010-07-14 AU AU2010272590A patent/AU2010272590B2/en not_active Ceased
- 2010-07-14 EA EA201270174A patent/EA201270174A1/ru unknown
- 2010-07-14 SG SG2012001855A patent/SG177601A1/en unknown
- 2010-07-14 BR BR112012001681A patent/BR112012001681A2/pt not_active IP Right Cessation
- 2010-07-14 JP JP2012520016A patent/JP2012532620A/ja active Pending
- 2010-07-14 KR KR1020127003939A patent/KR20120038494A/ko not_active Application Discontinuation
- 2010-07-14 IN IN640DEN2012 patent/IN2012DN00640A/en unknown
- 2010-07-14 CN CN2010800414331A patent/CN102574914A/zh active Pending
- 2010-07-14 WO PCT/EP2010/060112 patent/WO2011006915A2/fr active Application Filing
-
2012
- 2012-01-12 IL IL217520A patent/IL217520A0/en unknown
- 2012-01-13 ZA ZA2012/00276A patent/ZA201200276B/en unknown
-
2014
- 2014-01-30 US US14/168,168 patent/US20140140996A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012532620A (ja) | 2012-12-20 |
| IL217520A0 (en) | 2012-02-29 |
| EP2454285A2 (fr) | 2012-05-23 |
| ZA201200276B (en) | 2012-09-26 |
| WO2011006915A3 (fr) | 2011-03-03 |
| MX2012000765A (es) | 2012-02-13 |
| AU2010272590A1 (en) | 2012-02-02 |
| EA201270174A1 (ru) | 2012-07-30 |
| CA2768462A1 (fr) | 2011-01-20 |
| AU2010272590B2 (en) | 2013-10-10 |
| US20140140996A1 (en) | 2014-05-22 |
| KR20120038494A (ko) | 2012-04-23 |
| BR112012001681A2 (pt) | 2019-09-24 |
| SG177601A1 (en) | 2012-02-28 |
| WO2011006915A2 (fr) | 2011-01-20 |
| US20120114647A1 (en) | 2012-05-10 |
| US8679496B2 (en) | 2014-03-25 |
| CN102574914A (zh) | 2012-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN00640A (fr) | ||
| MX2011008752A (es) | Variantes de union a anti-albumina de suero mejoradas. | |
| MX2012013406A (es) | Variantes de union mejoradas anti-albumina serica. | |
| MX2011008749A (es) | Variantes de union a anti-albumina de suero mejoradas. | |
| CY1119567T1 (el) | Θεραπευτικα πεπτιδια | |
| WO2014083208A9 (fr) | Protéines de liaison comprenant au moins deux domaines de répétition dirigées contre her2 | |
| MX2012003939A (es) | Fusiones y conjugados de farmaco. | |
| WO2013072813A3 (fr) | Peptides cytotoxiques et conjugués anticorps-médicaments de ceux-ci | |
| WO2013130683A3 (fr) | Compositions de conjugués xten et leurs procédés de préparation | |
| EA201992456A3 (ru) | Самостабилизирующиеся линкерные конъюгаты | |
| UA110370C2 (en) | Conjugates of amatoxin with improved linkages | |
| WO2011123820A3 (fr) | Nouveaux colorants à la rhodamine et conjugués | |
| WO2011086143A3 (fr) | Molécules ciblant le foie | |
| UA106900C2 (uk) | Агоністичний dr5-зв'язувальний поліпептид | |
| WO2012072731A3 (fr) | Domaines variables améliorés à liaison unique d'anti-albumine sérique | |
| MX2013002055A (es) | Variantes anti-enlace de albumina de suero mejodas. | |
| MX2015014198A (es) | Anticuerpos cuyo objetivo es m-csf. | |
| CA3036643C (fr) | Agents de liaison monoclonaux cmet, conjugues medicamenteux connexes et utilisations | |
| WO2014044793A3 (fr) | Peptides de liaison à cd22 | |
| EP2569327A4 (fr) | Peptides de liaison à eif4e | |
| MX2016008478A (es) | Nuevo anticuerpo anti adam17 y su uso en el tratamiento del cancer. | |
| WO2008005470A3 (fr) | Polypeptides se liant aux protéines de membrane | |
| WO2016005474A8 (fr) | Conjugaison à sélectivité de site d'un conjugué oligonucléotidique ou d'une petite molécule à une protéine de liaison de métaux | |
| WO2012136792A3 (fr) | Compositions de cck | |
| CR20110473A (es) | Variantes de union a anti-albúmina de suero mejoradas. |